Get informed when a big investor buys or sells
+ FollowLoading insider trades…
Loading congress trades…
| Market cap | $9.30 Million |
|---|---|
| Enterprise Value | $9.92 Million |
| Earnings per Share | $- |
| Beta | 2.63 |
| Outstanding Shares | - |
| P/E Ratio | -0.2 |
|---|---|
| PEG | - |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | - |
| Enterprise Value to Net Income | - |
| Total Debt to Enterprise | 0.26 |
| Debt to Equity | 0.09 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
Khiron Life Sciences Corp. operates as a comprehensive medical and cannabis enterprise, extending its operations across Latin America and Europe. The company's business is structured into three primary segments: Health Services, Medical ...